宁心汤治疗冠心病室性早搏气虚挟痰瘀证的临床疗效及安全性

The Effect of Ningxin Decoction on Coronary Heart Disease Ventricular Premature Beats and Qi Deficiency and Phlegm and Blood Stasis Syndrome

目的探究宁心汤用于冠心病室性早搏气虚挟痰瘀证治疗的临床疗效与安全性。方法选取2016年1—12月收治的80例冠心病室性早搏气虚挟痰瘀证患者临床资料予以分析,将行常规西药治疗者作为对照组(35例),行宁心汤治疗者作为研究组(45例),比较两组中医症状评分与不良反应。结果治疗后研究组的中医症状评分较对照组差异具有统计学意义(P<0.05);两组不良反应差异无统计学意义(P>0.05)。结论冠心病室性早搏气虚挟痰瘀证患者经宁心汤治疗可有效减轻临床症状,减少早搏次数,且患者安全性高。

Objective To explore the clinical efficacy and safety of ningxin decoction in the treatment of coronary heart disease ventricular premature beats and qi deficiency and phlegm and blood stasis syndrome. Methods The clinical data of 80 patients with coronary heart disease ventricular premature beats and qi deficiency and phlegm and blood stasis syndrome from January to December 2016 were analyzed. The patients who were treated with routine western medicine were selected as control group （35 cases） and who treated with ningxin decoction were selected as study group （45 cases）, TCM symptom score and adverse reactions of the two groups were compared. Results After treatment, the TCM symptomscore between the two groups had significant statistic difference （P 〈 0.05）. There was no significant difference between the two groups about reverse reactions （P 〉 0.05）. Conclusion The treatment of ningxin decoction in the treatment of coronary heart disease ventricular premature beats and qi deficiency and phlegm and blood stasis syndrome can effectively reduce the clinical symptoms, reduce the number of premature beats, and the safety is high.